Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rangering i aksjer #31185
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aksjekurs
$0.03808538
Markedsverdi
$14.04M
Endring (1 dag)
-3.57%
Endring (1 år)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Kategori

Aksjeprishistorikk for BCAL Diagnostics Limited (BDX)
Høyeste sluttskurs: $0.04 den 2026-08-01

Laveste sluttskurs: $0.15 den 2021-07-01
Aksjeprishistorikk for BCAL Diagnostics Limited fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$591.22 21.26%
US
$200.34 -4.15%
US
$24.23 79.49%
CN
$312.51 93.92%
US
$557.21 -12.64%
US